Differentiation of silent corticotroph pituitary neuroendocrine tumors (PitNETs) from non-functioning PitNETs using kinetic analysis of dynamic MRI.
Humans
Pituitary Neoplasms
/ diagnostic imaging
Adenoma
/ diagnostic imaging
Corticotrophs
/ metabolism
Retrospective Studies
Neuroendocrine Tumors
/ diagnostic imaging
Kinetics
ACTH-Secreting Pituitary Adenoma
/ pathology
Pituitary Diseases
Adrenocorticotropic Hormone
/ metabolism
Magnetic Resonance Imaging
Dynamic contrast enhancement
Magnetic resonance imaging
Pituitary neuroendocrine tumor
Silent corticotroph pituitary neuroendocrine tumor
Journal
Japanese journal of radiology
ISSN: 1867-108X
Titre abrégé: Jpn J Radiol
Pays: Japan
ID NLM: 101490689
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
19
01
2023
accepted:
25
03
2023
medline:
1
9
2023
pubmed:
8
4
2023
entrez:
7
4
2023
Statut:
ppublish
Résumé
Silent corticotroph pituitary adenomas (SCAs)/pituitary neuroendocrine tumors (PitNETs) are common non-functioning pituitary adenomas (NFAs)/PitNETs with a clinically aggressive course. This study aimed to investigate the ability of time-intensity analysis of dynamic magnetic resonance imaging (MRI) for distinguishing adrenocorticotropic hormone (ACTH)-positive SCAs and ACTH-negative SCAs from other NFAs. We retrospectively evaluated the dynamic MRI findings of patients with NFAs. The initial slope of the kinetic curve (slope A total of 106 patients with NFAs (11 ACTH-positive SCAs, 5 ACTH-negative SCAs, and 90 other NFAs) were evaluated. The kinetic curves of ACTH-positive SCAs had significantly lesser slope Dynamic MRI can distinguish ACTH-positive SCAs and ACTH-negative SCAs from other NFAs.
Identifiants
pubmed: 37027094
doi: 10.1007/s11604-023-01420-3
pii: 10.1007/s11604-023-01420-3
pmc: PMC10468932
doi:
Substances chimiques
Adrenocorticotropic Hormone
9002-60-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
938-946Informations de copyright
© 2023. The Author(s).
Références
Jpn J Radiol. 2021 Aug;39(8):741-748
pubmed: 33881731
Clin Endocrinol (Oxf). 2014 Oct;81(4):566-72
pubmed: 24601912
Radiology. 1996 Sep;200(3):639-49
pubmed: 8756909
J Neurosurg. 2021 May 07;135(6):1706-1713
pubmed: 33962375
Semin Ophthalmol. 2009 May-Jun;24(3):185-9
pubmed: 19437356
Clin Endocrinol (Oxf). 2015 Feb;82(2):267-73
pubmed: 24801354
Magn Reson Med. 2008 Apr;59(4):747-54
pubmed: 18383287
Rev Endocr Metab Disord. 2020 Jun;21(2):213-223
pubmed: 31912365
Clin Endocrinol (Oxf). 2010 May;72(5):648-53
pubmed: 19650787
Yonsei Med J. 2013 Jan 1;54(1):123-30
pubmed: 23225808
Eur Radiol. 2018 Sep;28(9):3692-3701
pubmed: 29572634
Acad Radiol. 2019 Jul;26(7):e141-e149
pubmed: 30269956
Front Endocrinol (Lausanne). 2021 Jan 18;11:608691
pubmed: 33584540
Curr Med Sci. 2022 Dec;42(6):1111-1118
pubmed: 36544040
J Clin Endocrinol Metab. 2006 Dec;91(12):4769-75
pubmed: 16968795
Pituitary. 2018 Apr;21(2):111-118
pubmed: 29368293
J Endocrinol. 2000 May;165(2):475-81
pubmed: 10810311
Jpn J Radiol. 2023 Aug;41(8):789-806
pubmed: 36826759
Eur Radiol. 2022 Mar;32(3):1570-1578
pubmed: 34837512
AJR Am J Roentgenol. 2009 Apr;192(4):949-55
pubmed: 19304699
Eur J Endocrinol. 2018 Mar;178(3):265-276
pubmed: 29330228